Topics in Drug Testing from Quest Diagnostics
Episodes

Monday Oct 31, 2022
Ketamine: a re-emergence in medicine and misuse?
Monday Oct 31, 2022
Monday Oct 31, 2022
Learning objectives for the podcast include:
Learn how ketamine is increasingly being used as an anesthetic, analgesic, antidepressant, …and a hallucinogen1
Gain an understanding of the risks of ketamine use and ways it is misused
Appreciate the role of drug testing when ketamine is prescribed or suspected
You may download a PDF version of this presentation here >>
To listen to other podcasts in our Topics in Drug Testing series or learn more about the comprehensive drug testing offering from Quest Diagnostics, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.
1. Bahr R, Lopez A, Rey JA. Intranasal Esketamine(SpravatoTM) for use in treatment-resistant depression In conjunction with an oral antidepressant.P&T. 2019;44(6):340-375.

Thursday Aug 04, 2022
Windows of Detection
Thursday Aug 04, 2022
Thursday Aug 04, 2022
Objectives for the podcast include:
Understand drug metabolism and how prescription and illicit drugs and their metabolites are eliminated from the body
Learn about drug half-life and windows of detection, and how they are related
Gain a deeper understanding of specific variables that can impact a drug's window of detection
You may download a PDF version of this presentation here >>
To listen to other podcasts in our Topics in Drug Testing series or learn more about the comprehensive drug testing offering from Quest Diagnostics, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Wednesday Mar 30, 2022
Contributing Factors to the Skyrocketing Drug Misuse Epidemic in the US
Wednesday Mar 30, 2022
Wednesday Mar 30, 2022
Objectives for the podcast include:
Hear results from the recent Quest Diagnostics Health Trends report which combines data from a Harris Poll survey of over 500 primary care physicians, with results of clinical drug laboratory testing performed by Quest Diagnostics across the US
Gain a deeper understanding of the contributing factors to the significant surge in drug overdose deaths that we have seen in the US
Learn about barriers health professionals face in their ability to monitor and intervene with their patients at risk for drug misuse
You may download a PDF version of this presentation here >>
To listen to other podcasts in our Topics in Drug Testing series or learn more about the comprehensive drug testing offering from Quest Diagnostics, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insight to support your clinical decisions.

Wednesday Nov 03, 2021
Fentanyl: A substance of great concern
Wednesday Nov 03, 2021
Wednesday Nov 03, 2021
Today’s podcast will cover a substance of great concern today, fentanyl. We will discuss and share information regarding the following:
Latest trends in the drug misuse epidemic in the US
What you need to know about fentanyl
Why you need to consider drug testing for fentanyl (and other illicit substances) and how to implement drug testing in your practice
The episode will feature Quest Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain.
You may download a PDF version of this presentation here >>
To listen to other podcasts in our Topics in Drug Testing series, or learn more about Quest Diagnostics’ comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Friday Aug 27, 2021
Presumptive vs definitive drug testing: what you need to know
Friday Aug 27, 2021
Friday Aug 27, 2021
Today’s podcast will cover the value of prescription and illicit drug testing and provide insight on the different clinical drug testing methodologies. We will discuss and share information regarding the following:
Current state of the drug misuse epidemic in the US
The value and clinical utility of drug testing
Overview of the 2 main methodologies of drug testing, presumptive and definitive
The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Science Liaison Jack Kain, PharmD; and Executive Science Director, Les Edinboro, PhD.

Tuesday Jul 13, 2021
Pharmacogenomics in mental health and addiction
Tuesday Jul 13, 2021
Tuesday Jul 13, 2021
Today’s podcast discussion will focus on clinical care for patients with mental health disorders. Will discuss and share information regarding:
Mental health disorder and substance abuse prevalence
The clinical utility of pharmacogenomics in mental health and addiction
Mental health disorders and medication nonadherence
The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Director, Medical Science Liaison—Neurology and Pharmacogenomics, Raymond Lorenz.

Thursday Jun 03, 2021
Implementing a Drug Monitoring Protocol in your practice
Thursday Jun 03, 2021
Thursday Jun 03, 2021
Today’s podcast discussion will focus on appropriate steps to take to implement an effective Drug Monitoring Protocol in your practice. Key information shared will include:
Some of the key challenges facing clinicians today
Important steps to take for implementing a responsible drug monitoring protocol
How Quest can help
The episode will feature Quest Senior Medical Advisor, Dr Jeff Gudin; Medical Liaison Jack Kain, PharmD; and Senior Product Manager Jason Suomala, for the Quest Diagnostics Drug Monitoring and Toxicology division.

Friday Oct 23, 2020
Drug Monitoring in Behavioral Health and during times of crisis
Friday Oct 23, 2020
Friday Oct 23, 2020
Today’s podcast will cover the role of clinical drug monitoring in Behavioral Health and during times of crisis. Important information shared will include:
Mental Health disorders, diagnosis and prevalence
The challenge of medication adherence in mental health treatment
The impact of crises on the treatment of patients with mental health conditions
The role of clinical drug monitoring
The episode features Dr Jeff Gudin, senior medical advisor and Dr Jack Kain, medical science liaison for the Quest Diagnostics Drug Monitoring and Toxicology division.

Thursday Aug 27, 2020
Kratom: Identifying ”a drug of concern”
Thursday Aug 27, 2020
Thursday Aug 27, 2020
Today’s podcast will cover testing for kratom, a drug of concern. Some of the key information shared will include:
What is kratom?
What is the chemical make-up?
Kratom toxicity and side effects
Testing for kratom
Why testing is important?
How to test for kratom
What testing will tell you
This episode features Jack Kain, PharmD, Quest Diagnostics medical science liaison, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring.

Monday Apr 27, 2020
Why and when to use oral fluid testing
Monday Apr 27, 2020
Monday Apr 27, 2020
Today's podcast will cover why and when to use oral fluid testing. Some key topics shared will include:
What is oral fluid testing?
Comparison of oral fluid testing to other methods of testing
The benefits of oral fluid testing?
Some of the drugs oral fluid testing can identify?
How are the drugs identified?
How is the sample collected?
Discussion on some of the key collection issues
The episode features Les Edinboro, PhD, Quest Diagnostics executive science director, toxicology and drug monitoring, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring.